Exelixis' High Stakes Gamble on Zanzalintinib Exelixis' development of Zanzalintinib has generated significant interest in the cancer research community due to its potential as a game changer in treating certain types of tumors.
To understand this treatment's significance, it's essential to examine its background and the context of the research conducted so far.
The Science Behind Zanzalintinib: A Targeted Approach Zanzalintinib is a targeted therapy designed to inhibit specific kinases involved in cancer cell growth and proliferation.